Clinical Trial Update: A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating short-term use of darolutamide and its effects on human breast cancer tissue; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Translational Research in Oncology | Conditions: Breast Cancer Female | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-04-03